Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 31, 2025 14:50 ET | Source: Robbins LLP

AVTR Investor Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Avantor, Inc.

Robbins LLP is Investigating Allegations that Avantor, Inc. (AVTR) Mislead Investors Regarding the Effects of Increased Competition
October 27, 2025 17:24 ET | Source: Robbins LLP

MoonLake Stockholders with Large Losses are Encouraged to Contact Robbins LLP for Information About the Class Action Against MLTX

A class action alleges MoonLake misled investors about SLK’s Nanobody advantages over BIMZELX. Phase 3 results showed no superiority, sending shares down 8
October 22, 2025 20:57 ET | Source: Robbins LLP

NX Investors Should Contact Robbins LLP for Information Regarding the Upcoming Lead Plaintiff Deadline in the Quanex Building Products Corporation Class Action

Quanex’s stock fell 23% after revelations that its Mexico facility was underinvested, equipment degraded, and prior statements were misleading.
October 22, 2025 20:56 ET | Source: Robbins LLP

KBR Investors Should Contact Robbins LLP Regarding the Upcoming Lead Plaintiff Deadline in the KBR, Inc. Class Action

KBR’s stock fell after revelations that it misled investors about HomeSafe’s troubled DoD contract, which was later terminated due to ongoing performance.
October 22, 2025 20:48 ET | Source: Robbins LLP

CYTK Investors Should Contact Robbins LLP Regarding the Upcoming Lead Plaintiff Deadline in the Cytokinetics, Inc. Class Action

Cytokinetic stock fell after revelations it misled investors about aficamten’s FDA approval timeline and failed to disclose risks delaying the NDA process
October 22, 2025 20:40 ET | Source: Robbins LLP

JSPR Investors Should Contact Robbins LLP Regarding the Upcoming Lead Plaintiff Deadline in the Jasper Therapeutics, Inc. Class Action

Jasper’s stock fell 55% after disclosures that it lacked adequate controls over third-party manufacturers, misstating its compliance and operations.
October 20, 2025 14:40 ET | Source: Robbins LLP

BAX Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Filed Against Baxter International, Inc.

The Complaint Alleges that Baxter International Inc. (BAX) Mislead Investors Regarding the Safety of its Novum LVP
October 17, 2025 17:18 ET | Source: Robbins LLP

TROX Lead Plaintiff Deadline (11/3/25) Reminder: Tronox Holdings PLC Investors Should Contact Robbins LLP for Information About the Class Action Lawsuit

Tronox stock fell 38% after lowering its 2025 outlook and dividend. The complaint alleges defendants overstated demand and growth while downplaying risks.
October 17, 2025 16:52 ET | Source: Robbins LLP

SVRA Lead Plaintiff Deadline (11/7/25) Reminder: Savara Inc. Investors Should Contact Robbins LLP for Information About the Class Action Lawsuit

Savara stock declined 31.7% after the FDA declined to file its MOLBREEVI application, citing incomplete chemistry, manufacturing, and controls information.
October 17, 2025 16:43 ET | Source: Robbins LLP

MLTX Investor Notice: Robbins LLP Reminds Stockholders of the Securities Fraud Class Action Against MoonLake Immunotherapeutics

Robbins LLP is Investigating Allegations that MoonLake Immunotherapeutics (MLTX) Mislead Investors Regarding the Efficacy of its Drug Candidate